Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Wellgistics Health, Inc. incurred convertible notes of up to $8,125,000 in aggregate principal amount with certain investors at 0% except in the event of an event of default, in which case, the default intere maturing the six (6) month anniversary of the date of issuance of the Notes, or the date of closing of the next issuance and sale of capital stock of the Company.
- Instrument
- convertible notes
- Principal
- up to $8,125,000 in aggregate principal amount
- Counterparty
- certain investors
- Rate
- 0% except in the event of an event of default, in which case, the default intere
- Maturity
- the six (6) month anniversary of the date of issuance of the Notes, or the date of closing of the next issuance and sale of capital stock of the Company
- Event
- incurrence
Exact text from the filing
On January 16, 2026, Wellgistics Health, Inc. (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with certain investors (the “Investors”) whereby the Company agreed to issue and sell to the Investors in a private offering up to $8,125,000 in aggregate principal amount (the “Aggregate Principal Amount”) of secured convertible promissory notes (the “Notes”) (the “Offering”).
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Wellgistics Health, Inc. issued warrant to Placement Agent and its designees for 5% of aggregate gross proceeds.
- Security
- warrant
- Purchaser
- Placement Agent and its designees
- Consideration
- 5% of aggregate gross proceeds
Exact text from the filing
the Company issued common stock purchase warrants, in the form filed as Exhibit 10.2 to this Current Report on Form 8-K (the “PA Warrants”) to the Placement Agent and its designees to purchase a number of shares of Company common stock equal to 5% of the aggregate gross proceeds received by the Company with an exercise price equal to the closing price of the common stock on the last trading day before closing of the Offering.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Wellgistics Health, Inc. issued convertible note to certain investors (the "Investors") for up to $8,125,000 in aggregate principal amount; aggregate purchase price of $6,500,000.
- Security
- convertible note
- Purchaser
- certain investors (the "Investors")
- Consideration
- up to $8,125,000 in aggregate principal amount; aggregate purchase price of $6,500,000
Exact text from the filing
On January 16, 2026, Wellgistics Health, Inc. (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with certain investors (the “Investors”) whereby the Company agreed to issue and sell to the Investors in a private offering up to $8,125,000 in aggregate principal amount (the “Aggregate Principal Amount”) of secured convertible promissory notes (the “Notes”) (the “Offering”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Wellgistics Health, Inc. entered into Placement Agency Agreement with Dawson James Securities, Inc. (effective 2026-01-16).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Dawson James Securities, Inc.
- Effective
- 2026-01-16
Exact text from the filing
On January 16, 2026, in connection with the Offering, the Company entered into a placement agency agreement, a copy of which is filed as Exhibit 10.3 to this Current Report on Form 8-K (the “Placement Agency Agreement”) with Dawson James Securities, Inc. (the “Placement Agent”), pursuant to which the Placement Agent agreed to act as the Company’s placement agent in connection with the Offering.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Wellgistics Health, Inc. entered into Note Purchase Agreement with certain investors valued at up to $8,125,000 in aggregate principal amount (effective 2026-01-16).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- certain investors
- Value
- up to $8,125,000 in aggregate principal amount
- Effective
- 2026-01-16
Exact text from the filing
On January 16, 2026, Wellgistics Health, Inc. (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with certain investors (the “Investors”) whereby the Company agreed to issue and sell to the Investors in a private offering up to $8,125,000 in aggregate principal amount (the “Aggregate Principal Amount”) of secured convertible promissory notes (the “Notes”) (the “Offering”).
View on SEC.gov